Vasowatch, founded with a mission to enhance maternal health outcomes, focuses on providing innovative labor and delivery technology. Their core product is designed for continuous monitoring of a mother's risk for postpartum hemorrhage (PPH), the leading cause of maternal death and complications. By leveraging advanced decision support technology, Vasowatch aims to improve health equity and outcomes for mothers globally. Their market focus includes healthcare systems and payers dedicated to maternal health.
Notably, Vasowatch has been recognized by leading organizations in the maternal health field and has conducted significant observational studies at a large urban hospital in Pennsylvania. Their technology has demonstrated the ability to improve risk prediction for PPH up to ten times beyond the current standard of care. This breakthrough has the potential to significantly reduce maternal mortality and complications, making a substantial impact on global maternal health.
